EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dual-action antimicrobial peptide therapy: disrupting biofilm formation and targeting bacterial DNA for enhanced treatment of Pseudomonas aeruginosa endophthalmitis

Yi Tang iD, Yan-Jie Zhou, Zi-Chao Ning, Yue Zhang, Sheng Qu, Nan Li, Zhuo Hao, Zhan-Yuin Ong, Hong Wu iD

Microbiology Spectrum · 2026

DOI: 10.1128/spectrum.01180-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Yi Tang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Eye Center of Second Hospital, Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Biofilms, Pseudomonas aeruginosa, Endophthalmitis, Pseudomonas Infections. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Science and Technology of Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intraocular infections caused by Pseudomonas aeruginosa are difficult to treat due to bacterial biofilm-mediated antibiotic resistance. We used cationic polypeptide (XXYY) n to evaluate its effect and mechanism against Pseudomonas aeruginosa biofilm and its efficacy against Pseudomonas aeruginosa intraocular infection. Microbroth dilution showed that the MIC 90 of (LLKK) 3 C against Pseudomonas aeruginosa was 32 μg/mL. After continuous passage for 10 generations, the stability of antibacterial activity of (LLKK) 3 C against Pseudomonas aeruginosa was better than that of amikacin. TEM, SEM and live/dead staining demonstrated that (LLKK) 3 C was able to destroy the integrity of bacterial and biofilm and exert antibacterial activity by interacting with phosphatidyl glycerol on the membrane to destroy the bacterial membrane. Electrophoretic gel and Alphafold3 demonstrated that (LLKK) 3 C binds to bacterial DNA through charge interactions. In the rabbit endophthalmitis model, the intraocular bacterial load decreased after intravitreal injection (LLKK) 3 C treatment (vs untreated, P < 0.05). Studies have shown that (LLKK) 3 C has synergistic antibacterial effects through the dual mechanism of targeting membrane destruction and DNA binding, which provides a new treatment strategy for biomembrane-associated intraocular infections. IMPORTANCE Ocular infections caused by Pseudomonas aeruginosa often lead to severe vision loss due to antibiotic-resistant bacterial biofilms, which shield bacteria from conventional treatments. This study introduces (LLKK)3C, that uniquely attacks biofilms through a dual-action mechanism: physically disrupting bacterial membranes and binding to bacterial DNA. Unlike traditional antibiotics like amikacin, (LLKK)3C maintains robust antibacterial activity even after prolonged exposure, reducing the risk of resistance development. In a rabbit endophthalmitis model, (LLKK)3C significantly reduced intraocular bacterial loads, demonstrating its potential as a targeted therapy for sight-threatening infections. By addressing the dual challenges of biofilm resistance and drug stability, (LLKK)3C offers a promising strategy to improve clinical outcomes for patients with difficult-to-treat eye infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsPseudomonas aeruginosaEndophthalmitisPseudomonas InfectionsAnti-Bacterial AgentsDNA, BacterialAntimicrobial Cationic PeptidesAntimicrobial PeptidesAnimalsRabbitsMicrobial Sensitivity TestsDisease Models, Animal

Stichwörter der Autor:innen

Pseudomonas aeruginosaanti-microbial peptidesbacterial biofilmendophthalmitis

Substanzen

Anti-Bacterial AgentsDNA, BacterialAntimicrobial Cationic PeptidesAntimicrobial Peptides

Autor:innen und Institutionen

  • Eye Center of Second Hospital, Jilin University, Changchun, China.
  • Changchun Veterinary Research Institute, Changchun, China.
  • The School of Physics and Astronomy and School of Medicine, University of Leeds, Leeds, United Kingdom.

ORCID-Profile: Yi Tang, Hong Wu

Förderung

  • Department of Science and Technology of Jilin Province

Zitieren

APA

Tang, Y., Zhou, Y. J., Ning, Z. C., Zhang, Y., Qu, S., Li, N., Hao, Z., Ong, Z. Y., & Wu, H. (2026). Dual-action antimicrobial peptide therapy: disrupting biofilm formation and targeting bacterial DNA for enhanced treatment of Pseudomonas aeruginosa endophthalmitis. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01180-25

Vancouver

Tang Y, Zhou YJ, Ning ZC, Zhang Y, Qu S, Li N, et al. Dual-action antimicrobial peptide therapy: disrupting biofilm formation and targeting bacterial DNA for enhanced treatment of Pseudomonas aeruginosa endophthalmitis. Microbiology Spectrum. 2026. doi:10.1128/spectrum.01180-25

BibTeX
@article{Tang2026,
  author = {Tang, Yi and Zhou, Yan-Jie and Ning, Zi-Chao and Zhang, Yue and Qu, Sheng and Li, Nan and Hao, Zhuo and Ong, Zhan-Yuin and Wu, Hong},
  title = {Dual-action antimicrobial peptide therapy: disrupting biofilm formation and targeting bacterial DNA for enhanced treatment of Pseudomonas aeruginosa endophthalmitis},
  journal = {Microbiology Spectrum},
  year = {2026},
  doi = {10.1128/spectrum.01180-25}
}
Kostenlos starten →